|
Re: We Need The Futility Analysis
|
3
|
Resverlogix Corp.
|
Feb 07, 2018 08:59PM
|
|
Re: Can we expect another plea from DM Monday?
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 06:29PM
|
|
Competition
|
3
|
Resverlogix Corp.
|
Nov 28, 2021 11:28AM
|
|
Re: ..the blog post in full> by Van Leeuwenhoeck's Marcel Wijma...
|
3
|
Resverlogix Corp.
|
Jul 02, 2015 02:38PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 09:58AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Feb 09, 2019 02:45PM
|
|
Re: How to best promote apabetalone?
|
3
|
Resverlogix Corp.
|
Oct 30, 2017 05:27PM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
3
|
Resverlogix Corp.
|
Mar 11, 2021 11:36AM
|
|
Re: My Non-Scientific Net-Net Preliminary Conclusions
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 07:47PM
|
|
Vote - please
|
3
|
Zenith Epigenetics
|
Oct 04, 2023 01:06PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 15, 2022 11:37AM
|
|
Re: IR
|
3
|
Resverlogix Corp.
|
Jan 18, 2023 11:32AM
|
|
Re: For those complaining about the money DM makes....
|
3
|
Resverlogix Corp.
|
May 07, 2016 11:54AM
|
|
Re: Internal mail
|
3
|
Resverlogix Corp.
|
May 23, 2015 12:10PM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
3
|
Resverlogix Corp.
|
Jul 28, 2015 11:49AM
|
|
Re: Trials and statistics, next steps
|
3
|
Resverlogix Corp.
|
Feb 11, 2020 04:21PM
|
|
Value of the accumulated deficit - a question
|
3
|
Resverlogix Corp.
|
Apr 17, 2019 04:39PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 14, 2022 06:20PM
|
|
Re: Webcast is up
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 08:10PM
|
|
Re: Stability
|
3
|
Resverlogix Corp.
|
Nov 23, 2015 03:26PM
|
